Retina/Vitreous

Top Story

Ophthotech gives update on retinal disease pipeline

January 15, 2019
Blog

BLOG: Laser still has an important role in diabetic eye disease

January 14, 2019
There is no question that the introduction of anti-VEGF agents has dramatically changed the landscape of how surgeons approach retinal diseases. New drugs continue to…

OSN’s top stories of the week

January 13, 2019
Here are the top five stories on Healio.com/OSN last week:
In the JournalsPerspective

One in four anti-VEGF therapy patients with DME lost to follow-up

January 11, 2019
A quarter of patients with diabetic macular edema who received an anti-VEGF injection to treat nonproliferative diabetic retinopathy did not return for a follow-up visit…
More Headlines »
Case Report

Retinal Metastasis Simulating Cytomegalovirus Retinitis

Ophthalmic Surgery, Lasers and Imaging Retina, Volume 4
Online Only, July 1, 2012
A 62-year-old man with lung cancer presented with a 2-week history of decreased vision and clinical features of…
More »
CME

Providing Defense at the Ocular Surface: Managing Dry Eye

This activity is supported by an educational grant from Shire.

This CME activity will discuss modalities for diagnosing ocular surface disease as well as assess the attributes and…
More »
Video
Meeting News

VIDEO: Allegro updates progress of Luminate for DME

November 2, 2018
More »

Ophthotech gives update on retinal disease pipeline

January 15, 2019
With eight products in its pipeline, Ophthotech is aiming to lead the gene therapy front for retinal diseases, Glenn P. Sblendorio

Blog

BLOG: Laser still has an important role in diabetic eye disease

January 14, 2019
There is no question that the introduction of anti-VEGF agents has dramatically changed the landscape of how surgeons approach retinal diseases. New…

OSN’s top stories of the week

January 13, 2019
Here are the top five stories on Healio.com/OSN last week:

In the JournalsPerspective

One in four anti-VEGF therapy patients with DME lost to follow-up

January 11, 2019
A quarter of patients with diabetic macular edema who received an anti-VEGF injection to treat nonproliferative diabetic retinopathy did not return…

Allergan reports continued focus on eye care business

January 10, 2019
Allergan’s commitment to its eye care business includes advancing new products for both the front and back of the eye, CEO Brent Saunders said…

Optometry must follow neurology’s standard of care in retinal artery obstruction

January 10, 2019
Neurologists consider an acute retinal artery obstruction a true medical emergency and classify it as a stroke. Scott C.

In the Journals

Large data set correlates cholesterol levels with AMD

January 9, 2019
HDL cholesterol and triglycerides have, respectively, a positive and negative association with increased risk for age-related macular degeneration…

Meeting NewsVideo

VIDEO: Leber hereditary optic neuropathy gene therapy shows positive results

January 9, 2019
CHICAGO — Mark L. Moster, MD, of Wills Eye Hospital, discusses results of the REVERSE clinical trial, which is evaluating the efficacy of…

In the Journals

Ciliary neurotrophic factor may benefit patients with macular telangiectasia type 2

January 9, 2019
Intravitreal sustained delivery of human ciliary neurotrophic factor showed efficacy in slowing the progression of retinal degeneration in patients…

ProQR to begin phase 2/3 trial of treatment for Leber’s congenital amaurosis 10

January 8, 2019
ProQR Therapeutics and the FDA have reached an agreement regarding the design of the phase 2/3 ILLUMINATE trial of the company’s RNA-based…

BioTime, Orbit Biomedical to collaborate on OpRegen subretinal delivery for dry AMD

January 8, 2019
BioTime has entered into a research and option agreement with Orbit Biomedical regarding technology to deliver OpRegen to treat dry age-related…

Grand Rounds at the New England Eye Center

Woman presents with decreased night vision

Ocular Surgery News U.S. Edition, January 25, 2019
Eleni Konstantinou, MD; Laurel Vuong, MD
A 56-year-old Caucasian woman was referred from an outside office to the Neuro-ophthalmology service at the New England Eye Center for evaluation of…

Vital dyes necessary for vitreomacular surgery but may have risks

Ocular Surgery News U.S. Edition, January 25, 2019
Vital dyes are used by vitreoretinal specialists to visualize transparent preretinal tissues, to enhance identification and to remove transparent…

Gemini to initiate CLARITY dry AMD disease registry and study

January 7, 2019
Gemini Therapeutics announced a disease registry and natural history study to identify and characterize disease progression in patients with…

In the Journals

Laser-induced chorioretinal anastomosis can lessen CRVO treatment burden

January 4, 2019
Adding laser-induced chorioretinal anastomosis to anti-VEGF treatment for central retinal vein occlusion can reduce the number of injections needed…

EyePoint plans accelerated Dexycu launch

January 4, 2019
EyePoint Pharmaceuticals will launch both Dexycu and Yutiq in the first quarter, the company announced in a press release. The two drugs were…

Anti-VEGF injections may play increasing role in treatment of diabetic retinopathy

Ocular Surgery News U.S. Edition, January 10, 2019
Patients with diabetic macular edema and moderately severe to severe nonproliferative diabetic retinopathy, as determined on the ETDRS Diabetic…

Grand Rounds at the New England Eye Center

Woman presents with blurred vision 1 year after cataract surgery

Ocular Surgery News U.S. Edition, January 10, 2019
Adam T. Chin, MD; Shilpa J. Desai, MD; Thomas R. Hedges III, MD
A 65-year-old retired grocery store clerk was referred to the New England Eye Center with more than a year of progressive vision loss in the right…

ProQR’s Usher syndrome treatment gets fast track designation

January 2, 2019
The FDA has granted a fast track designation for QR-421a, an investigational treatment for vision loss associated with Usher syndrome type 2 and…

In the Journals

BCVA may be viable primary outcome in gene therapy trials for choroideremia

December 31, 2018
Best corrected visual acuity was sustained or improved in patients with choroideremia who underwent gene therapy in a phase 2 study, and the…

More Headlines »